In this episode of Lung Cancer Considered, host Dr. Narjust Florez and two esteemed oncology colleagues discuss an evolving hot topic: the use of immune checkpoint inhibitors in the treatment of patients with molecular driven non-small cell lung cancer.

Guest: Dr. Erin Schenk is an Assistant Professor of Medicine in the section of Medical Oncology at the University of Colorado and the Director of the Schenk Laboratory
X: @SchenkLab

Guest: Dr. Biagio Ricciuti is a Thoracic Medical Oncologist and Data Scientist at Dana-Farber Cancer Institute and Harvard Medical School
X: @BiagioRicciutMD

Ver todos los episodios